CVRdatabase
Menu

CanNordic a/s

Public limited companyCVR 33871902København ØActive

CanNordic a/s is a public limited company, based in København Ø, active in manufacture of pharmaceutical preparations, founded in 2011. The company made a loss in both 2024 and 2025, most recently DKK 6.2m. Equity fell to DKK 4.3m in 2025.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profit−DKK 100k+79% vs. 2024
Net profit−DKK 6.2m−27.4% vs. 2024
EquityDKK 4.3m−59.1% vs. 2024
Employees5latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • The loss grew: from DKK 4.9m to DKK 6.2m (2024 → 2025).
  • Equity fell 59% (2024 → 2025), to DKK 4.3m.

Employees

  • 1 fewer employees than a year earlier: 5 (08/2026) against 6 (08/2025).

Management and owners, last 24 months

  • New in management: Lone Henriksen (board member, 28/03/2025), Jens Jørgen Hagelskjær (board member, 01/04/2026) and Mads Verner Jørgensen (board member, 28/03/2025).
  • Stepped down: Anders Permin (board member, 28/03/2025), Ib Madsen (board member, 28/03/2025) and Flemming Heegaard (chair of the board, 28/03/2025) (+2).

Registrations, last 24 months

  • 16/09/2026: Share capital changed from 15,500,000 DKK to 500,000 DKK
  • 12/11/2024: Share capital changed from 500,000 DKK to 15,500,000 DKK

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 10m−DKK 8m−DKK 6m−DKK 4m−DKK 2mDKK 0DKK 2mDKK 4mDKK 6mDKK 8mDKK 10m202020212022202320242025
EquityNet profit
Financial figures for CanNordic a/s
202020212022202320242025Change
Revenuenot stated3,157not statednot statednot statednot stated–
Gross profit7752,439503−3,919−478−100+79%
Operating profit (EBIT)120868−5,114−9,682−5,415−5,888−8.8%
Profit before tax−24643−5,684−10,724−6,479−6,484−0.1%
Net profit−461,480−4,299−8,240−4,882−6,220−27.4%
Total assets5,51211,86421,37318,96919,94018,559−6.9%
Equity471,94064140010,5194,299−59.1%
Liabilities4,2119,59520,56818,5689,42214,260+51.3%
Cash and cash equivalents296376141918+751.1%
Average number of employees2457550%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 4m−DKK 3m−DKK 2m−DKK 1mDKK 0DKK 1mDKK 2mDKK 3m202020212022202320242025
Gross profitMedian, the industry (59 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Loss for 4 years in a row

    Net result has been negative in 2022–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

  • Equity fell sharply

    Equity fell 59% from 2024 to 2025 (DKK 10.5m to DKK 4.3m).

    How is this calculated?

    Equity has fallen by at least 30% from the previous annual report, and it was positive the year before.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for CanNordic a/s
Financial yearPeriodPublishedFigures forDocuments
202501/10/2024 – 30/09/202510/04/2026The companyPDF not statedXBRL
202401/10/2023 – 30/09/202408/04/2025The companyPDFXBRL
202301/10/2022 – 30/09/202310/04/2024The companyPDFXBRL
202201/10/2021 – 30/09/202217/04/2023The companyPDFXBRL
202101/10/2020 – 30/09/202103/01/2022The companyPDFXBRL
202001/10/2019 – 30/09/202029/12/2020The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
024681009/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

59 companies in the database

Comparison with the other companies in manufacture of pharmaceutical preparations based on the latest financial year.

Gross profit−DKK 100kNo. 37 of 57
Better than 36% of the companies in the industry
EquityDKK 4.3mNo. 33 of 59
Better than 45% of the companies in the industry
Number of employees5No. 33 of 59
Better than 45% of the companies in the industry

Industry median: gross profit DKK 2.8m, net profit −DKK 2.2m, equity DKK 5.2m, 10 employees.

DKK 266kDKK 8.3mDKK 258mDKK 8bnDKK 79.6bn
Distribution of gross profit for 34 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 65,955of 69,742
Better than 5%
No. 15,617of 69,964
Better than 78%
Same industry and fewer than 20 employees37 companies in the comparison
No. 19of 36
Better than 49%
No. 15of 37
Better than 61%
Companies that are between 15 and 29 years old24,910 companies in the comparison
No. 23,513of 24,791
Better than 5%
No. 10,484of 24,909
Better than 58%
All companies of type A/S18,025 companies in the comparison
No. 16,872of 17,786
Better than 5%
No. 12,088of 18,024
Better than 33%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Manufacture of pharmaceutical preparations
Gross profit
  1. CanNordic a/s−DKK 100k
  2. Novo Nordisk A/SDKK 250.3bn
  3. H. Lundbeck A/SDKK 20.4bn
Net profit
  1. CanNordic a/s−DKK 6.2m
  2. Novo Nordisk A/SDKK 102.4bn
  3. H. Lundbeck A/SDKK 3.2bn
Equity
  1. CanNordic a/sDKK 4.3m
  2. Novo Nordisk A/SDKK 194bn
  3. H. Lundbeck A/SDKK 24.9bn
Employees
  1. CanNordic a/s5
  2. Novo Nordisk A/S27,279
  3. H. Lundbeck A/S2,261

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • CS Medica A/S100%
CanNordic a/s

Management

4 active registrations

Executive management

Executive management at CanNordic a/s
NameRoleAppointed
Lone HenriksenCEO16/04/2021

Board of directors

Board of directors at CanNordic a/s
NameRoleAppointed
Gitte HenriksenBoard member01/07/2021
Lone HenriksenBoard member28/03/2025
Jens Jørgen HagelskjærBoard member01/04/2026
Founders
Nes Holding 1 ApS, CS Medica A/S
Former management (13)
Former management at CanNordic a/s
NameRoleAppointedResigned
Niels Erik SchønbergDirector19/08/201129/08/2014
Lone HenriksenDirector19/08/201115/04/2021
Gitte HenriksenChair of the board16/04/202130/06/2021
Jørgen Flemming LadefogedBoard member16/04/202130/06/2021
Anders PerminBoard member16/04/202128/03/2025
Stein Arve LøkstadBoard member16/04/202114/04/2023
Bo Erik Lennart UnéusBoard member16/04/202125/10/2022
Jørgen Flemming LadefogedChair of the board01/07/202109/04/2024
Alexandre FevreBoard member09/02/202220/09/2023
Ib MadsenBoard member09/04/202428/03/2025
Flemming HeegaardChair of the board09/04/202428/03/2025
Jesper Herold HalleBoard member09/04/202428/03/2025
Mads Verner JørgensenBoard member28/03/202510/04/2025

Signing rule: Selskabet tegnes af den administrerende direktør i forening med et bestyrelsesmedlem, af tre medlemmer af bestyrelsen eller af den samlede bestyrelse.

Address and production units

1 active production units

Indiakaj 10
2100 København Ø

København Municipality · Postcode 2100

Production units
Production unitAddressEmployeesP number
CanNordic a/sIndiakaj 10, 2, 2100 København Ø51017068535

Purpose

Selskabets formål er at drive medicinalvirksomhed og hermed forbundet virksomhed.

The purpose is quoted from the register in Danish.

Changes year by year

51 registered events
20263 changescapital 1 · accounts 1 · management 1
  • Share capital changed from 15,500,000 DKK to 500,000 DKK
  • Annual report for 2025 published
  • Jens Jørgen Hagelskjær appointed board member
20258 changesmanagement 7 · accounts 1
  • Mads Verner Jørgensen stepped down as board member
  • Annual report for 2024 published
  • Lone Henriksen appointed board member
  • Mads Verner Jørgensen appointed board member
  • Ib Madsen stepped down as board member
  • Jesper Herold Halle stepped down as board member
  • Flemming Heegaard stepped down as chair of the board
  • Anders Permin stepped down as board member
20246 changescapital 1 · accounts 1 · management 4
  • Share capital changed from 500,000 DKK to 15,500,000 DKK
  • Annual report for 2023 published
  • Ib Madsen appointed board member
  • Jesper Herold Halle appointed board member
  • Flemming Heegaard appointed chair of the board
  • Jørgen Flemming Ladefoged stepped down as chair of the board
20234 changesmanagement 2 · address 1 · accounts 1
  • Alexandre Fevre stepped down as board member
  • Moved to Indiakaj 10, 2, 2100 København Ø
  • Annual report for 2022 published
  • Stein Arve Løkstad stepped down as board member
20223 changesmanagement 2 · accounts 1
  • Bo Erik Lennart Unéus stepped down as board member
  • Alexandre Fevre appointed board member
  • Annual report for 2021 published
202115 changesmanagement 11 · address 1 · name 1 · industry 1 · capital 1
  • Jørgen Flemming Ladefoged appointed chair of the board
  • Gitte Henriksen appointed board member
  • Jørgen Flemming Ladefoged stepped down as board member
  • Gitte Henriksen stepped down as chair of the board
  • Moved to Fruebjergvej 3, 2100 København Ø
  • Name changed from GALAXA PHARMA ApS to CanNordic a/s
  • Industry changed to Manufacture of pharmaceutical preparations (212000)
  • Share capital changed from 87,000 DKK to 500,000 DKK
  • Stein Arve Løkstad appointed board member
  • Anders Permin appointed board member
  • Lone Henriksen appointed ceo
  • Jørgen Flemming Ladefoged appointed board member
  • Bo Erik Lennart Unéus appointed board member
  • Gitte Henriksen appointed chair of the board
  • Lone Henriksen stepped down as director
20203 changesaccounts 1 · capital 2
  • Annual report for 2020 published
  • Share capital changed from 85,000 DKK to 87,000 DKK
  • Share capital changed from 80,000 DKK to 85,000 DKK
20161 changeaddress 1
  • Moved to Korskildelund 6, 2670 Greve
20151 changeaddress 1
  • Moved to Glostrupvej 13D, Egebjerg, 4500 Nykøbing Sj
20143 changesownership 1 · management 1 · address 1
  • CS MEDICA a/s registered as owner (100%)
  • Niels Erik Schønberg stepped down as director
  • Moved to Rørvigvej 3, 4500 Nykøbing Sj
20121 changeindustry 1
  • Industry changed to Wholesale of pharmaceutical goods and nursing supplies (464610)
20113 changesfounded 1 · management 2
  • Registered as GALAXA PHARMA ApS
  • Lone Henriksen appointed director
  • Niels Erik Schønberg appointed director

Related companies

Same industry in København

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction